- Report
- April 2024
- 184 Pages
Global
From €3975EUR$4,500USD£3,483GBP
From €3092EUR$3,500USD£2,709GBP
- Report
- November 2023
- 149 Pages
Asia Pacific
From €3534EUR$4,000USD£3,096GBP
- Report
- November 2023
- 180 Pages
Global
From €3975EUR$4,500USD£3,483GBP
From €3092EUR$3,500USD£2,709GBP
- Report
- October 2023
- 70 Pages
Egypt
From €3092EUR$3,500USD£2,709GBP
- Report
- October 2023
- 173 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Report
- October 2023
- 70 Pages
Malaysia
From €3092EUR$3,500USD£2,709GBP
- Report
- August 2023
- 76 Pages
Spain
From €3092EUR$3,500USD£2,709GBP
- Report
- August 2023
- 76 Pages
South Korea
From €3092EUR$3,500USD£2,709GBP
- Report
- August 2023
- 78 Pages
Egypt
From €3092EUR$3,500USD£2,709GBP
- Report
- August 2023
- 79 Pages
Mexico
From €3092EUR$3,500USD£2,709GBP
- Report
- March 2023
- 116 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Report
- March 2023
- 118 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1413EUR$1,600USD£1,238GBP
€1767EUR$2,000USD£1,548GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1413EUR$1,600USD£1,238GBP
€1767EUR$2,000USD£1,548GBP
- Report
- July 2024
- 100 Pages
Global
From €2650EUR$3,000USD£2,322GBP
€3313EUR$3,750USD£2,902GBP
- Report
- July 2024
- 150 Pages
Global
From €2650EUR$3,000USD£2,322GBP
€3313EUR$3,750USD£2,902GBP
- Report
- February 2023
- 82 Pages
Global
From €2792EUR$3,160USD£2,446GBP
€3489EUR$3,950USD£3,057GBP
- Report
- July 2024
- 120 Pages
Global
From €4196EUR$4,750USD£3,676GBP

The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more